iRhythm Holdings, Inc. (IRTC) Q3 2025 10-Q Quarterly Report
Filed: Oct 30, 2025Period ending Sep 30, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR iRhythm Holdings, Inc. (IRTC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
iRhythm Holdings, Inc. Q3 2025 10-Q Analysis
Risk Factors
- • No new or updated risk factors disclosed in this 10-Q vs prior 10-K
- • Regulatory risk: ongoing dependence on FDA device clearance and evolving healthcare reimbursement policies
iRhythm Holdings, Inc. Q3 2025 Quarterly FinancialsXBRL
Revenue
$193M
▲ +30.7% YoY▲ +3.3% QoQ
Net Income
-$5M
▲ +88.7% YoY▲ +63.3% QoQ
Gross Margin
71.1%
▲ +231bp YoY▼ -8bp QoQ
Operating Margin
-4.4%
▲ +2972bp YoY▲ +565bp QoQ
Net Margin
-2.7%
▲ +2860bp YoY▲ +491bp QoQ
ROE
-4.3%
Total Assets
$995M
EPS (Diluted)
$-0.16
▲ +89.1% YoY▲ +63.6% QoQ
Operating Cash Flow
$35M
▲ +43.3% YoY▲ +26.1% QoQ
Source: XBRL data from iRhythm Holdings, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on iRhythm Holdings, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.